Lebanon vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Lebanon
100.0%
in 2024
Mongolia
100.0%
in 2024
Lebanon rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lebanon
- Mongolia
How they compare
Lebanon currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 7 times across 16 shared years of data; in 2007 it was Lebanon ahead.
Lebanon ranks 1st and Mongolia ranks 1st of 144 countries.
Across the 3 decades both report, Lebanon averaged higher in 2 and Mongolia in 1.
Head to head by decade
| Decade | Lebanon | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 66.5% | 33.5% | Lebanon |
| 2010s | 88.5% | 78.1% | 10.4% | Lebanon |
| 2020s | 91.8% | 100.0% | 8.2% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lebanon or Mongolia?
- Lebanon, at 100.0% against 100.0% in Mongolia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lebanon and Mongolia?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Mongolia?
- 16 years are reported by both, from 2007 to 2024.
- How do Lebanon and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lebanon ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.